Sinopep-Allsino Bio Pharmaceutical Co., Ltd.SSE: 688076

2025 Semi-annual Report

Aug 21, 2025 · Issued by Sinopep-Allsino Bio Pharmaceutical Co., Ltd. via Shanghai Stock Exchange

Filed with SSE · Aug 21, 2025

On 6ix: 6ix.com/news/2025-semi-annual-report-433

2025 Semi-annual Report

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment

6ix hasn’t read this filing yet.

Sinopep-Allsino Bio Pharmaceutical Co., Ltd. on 6ix

Earlier from Sinopep-Allsino Bio Pharmaceutical

Announcement on Voluntary Disclosure of Passing cGMP Site Inspection for DrugsAug 6, 2025
Announcement on the Voluntary Disclosure of Receiving Drug Registration Certificates for Sequiretic Acetate Injection and Agomelatine TabletsAug 1, 2025
Announcement on Implementation of Other Risk Warnings and Trading SuspensionJul 19, 2025
Announcement on Voluntary Disclosure of Earnings Preannouncement for 2025 Interim ResultsJul 4, 2025
Announcement on Adjusting Matters Related to the 2023 Restricted Stock Incentive PlanJun 27, 2025

Later from Sinopep-Allsino Bio Pharmaceutical

Announcement on Resolutions of the 1st Extraordinary General Meeting in 2025Sep 6, 2025
Announcement on Voluntary Disclosure of Earnings Preannouncement for Q3 2025Oct 11, 2025
Report for Q3 2025Oct 23, 2025
Announcement on Voluntary Disclosure of Agomelatine Tablets Prospective Winning of the 11th National Centralized Drug ProcurementOct 29, 2025
Announcement on Voluntary Disclosure of Obtaining Drug Registration Certificate for Atosiban Acetate InjectionDec 10, 2025

All Sinopep-Allsino Bio Pharmaceutical news releases

Follow Sinopep-Allsino Bio Pharmaceutical into a list and get an email when it puts out news.

Follow Sinopep-Allsino Bio Pharmaceutical